{"id":754909,"date":"2023-05-04T09:42:31","date_gmt":"2023-05-04T13:42:31","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-to-host-first-quarter-2023-financial-results-and-company-update-conference-call-and-webcast-on-may-11-2023\/"},"modified":"2023-05-04T09:42:31","modified_gmt":"2023-05-04T13:42:31","slug":"dare-bioscience-to-host-first-quarter-2023-financial-results-and-company-update-conference-call-and-webcast-on-may-11-2023","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-to-host-first-quarter-2023-financial-results-and-company-update-conference-call-and-webcast-on-may-11-2023\/","title":{"rendered":"Dar\u00e9 Bioscience to Host First Quarter 2023 Financial Results and Company Update Conference Call and Webcast on May 11, 2023"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">SAN DIEGO, May  04, 2023  (GLOBE NEWSWIRE) &#8212; Dar\u00e9 Bioscience, Inc. (NASDAQ: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=HAkrd4XDL2FDE-baJEoPsw1whO3qChojpdM35I6YdyscvJoAwy6Dkgj3vAN6thjENBDzwOpqKUxyG-4573qb7Goi2KDXUoIn_-OQCaHG4g046MMOfG__NdREimhnJn9ucxVi7QWsTxTZWvjwUOAusTNcjTSfj4WmmROguQq0F8Br8N5VdVtpXnOzE6zg-5bXtJDPlxqP1rE0yEK-xiwH1_h6qADPG6yg2gAA6HHugBPjUU6qXnrMDQ_Iq4Rp0tIq\" rel=\"nofollow noopener\" target=\"_blank\">DARE<\/a>), a leader in women\u2019s health innovation, today announced that it will host a conference call and live webcast at 4:30 p.m. Eastern Time on Thursday, May 11, 2023, to review its financial results for the quarter ended March 31, 2023 and to provide a Company update.<\/p>\n<p align=\"justify\">To access the conference call via phone, dial (800) 715-9871 (U.S.) or (646) 307-1963 (international). The conference ID number for the call is 7046999. The live webcast can be accessed under \u201cPresentations, Events &amp; Webcasts&#8221; in the Investors section of the Company&#8217;s website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ASaB-_22psEvUbY5vfVaSGv_nRQuCpZsmtMmKEt0Q7xC5j26CjCbooXgIqOnDYD3o0xiG_6vgo6gC6qrp68Vc2Lu8LsdbzSdq8sbmSAiZ34=\" rel=\"nofollow noopener\" target=\"_blank\">http:\/\/ir.darebioscience.com<\/a>. Please log in approximately 5-10 minutes prior to the call to register and to download and install any necessary software. The webcast will be archived under \u201cPresentations, Events &amp; Webcasts&#8221; in the Investors section of the Company&#8217;s website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ASaB-_22psEvUbY5vfVaSGv_nRQuCpZsmtMmKEt0Q7yK8EBp2kJDgjowgfNWunnIx7Az3Vzy7R8Fbay5q2ZeqAVFc3dqf8ulw4u6YAOG0es=\" rel=\"nofollow noopener\" target=\"_blank\">http:\/\/ir.darebioscience.com<\/a>\u00a0and available for replay until\u00a0May 25, 2023.<\/p>\n<p align=\"justify\">\n        <strong>About Dar\u00e9 Bioscience<\/strong>\n      <\/p>\n<p align=\"justify\">Dar\u00e9 Bioscience is a biopharmaceutical company committed to advancing innovative products for women\u2019s health. The company\u2019s mission is to identify, develop and bring to market a diverse portfolio of differentiated therapies that prioritize women&#8217;s health and well-being, expand treatment options, and improve outcomes, primarily in the areas of contraception, vaginal health, reproductive health, menopause, sexual health and fertility.<\/p>\n<p align=\"justify\">Dar\u00e9\u2019s first FDA-approved product, XACIATO\u2122 (clindamycin phosphate) vaginal gel, 2% is a lincosamide antibacterial indicated for the treatment of bacterial vaginosis in female patients 12 years of age and older, which is under a global license agreement with Organon. XACIATO is a clear, colorless, viscous gel, to be administered once intravaginally as a single dose. Dar\u00e9\u2019s portfolio also includes potential first-in-category candidates in clinical development: Ovaprene<sup>\u00ae<\/sup>, a novel, hormone-free monthly intravaginal contraceptive whose\u00a0U.S.\u00a0commercial rights are under a license agreement with Bayer; Sildenafil Cream, 3.6%, a novel cream formulation of sildenafil to treat female sexual arousal disorder utilizing the active ingredient in Viagra<sup>\u00ae<\/sup>; and DARE-HRT1, a combination bio-identical estradiol and progesterone intravaginal ring for menopausal hormone therapy. To learn more about XACIATO, Dar\u00e9\u2019s full portfolio of women\u2019s health product candidates, and Dar\u00e9\u2019s mission to deliver differentiated therapies for women, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=zYA4avnm0QDV-h7G-x-riaTaVNm4ky8lEkb33PY5g8f27I-peU-NC15xcXXSA1fhNjqlANgCcGRx1VvnOsJ7iWCkRr0yA_ArK3vdGQMmg6V7-YVaTp2jbZ7zVmAf45Rcl9_q3-L5ND8j2SITBVlF63322vmPMNwsHQOOUlM0GNI969s-HvNdD8dHuabImSix3Fs3Qbk75jUo4d3y3eq9riN6ly8cbJ6GmMgVt5vya_6k6egYXjP09vMFJE7ITj6EFxwFMPibAz62aSP9TYgqVQ==\" rel=\"nofollow noopener\" target=\"_blank\">www.darebioscience.com<\/a>.<\/p>\n<p align=\"justify\">Dar\u00e9 may announce material information about its finances, product and product candidates, clinical trials and other matters using the Investors section of its website (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ASaB-_22psEvUbY5vfVaSGv_nRQuCpZsmtMmKEt0Q7zYVx_6gjubVSv6G3k2R_1zosXk_n1MB3Dgrvd3CX-1tUO5hCNHpCQjDpevjc4_qVMyVVg64d4xNcjxXixROvFNJVEuZX3y59aFww3rhK6RLhHllgvYglSRYY0NhHJ_Cx57cYvxOrOA7uTfWLu4LtxvQocQSF-SaLppIntDCb5lkje4bjkxNfmQMBDdjX0wvPPI0GB35ZQb2UXAEt2zSZ-AShlSxkP5nxlfhRPt2Ylc8VbZxJ6T8gFtrKjGt0WfqeA=\" rel=\"nofollow noopener\" target=\"_blank\">http:\/\/ir.darebioscience.com<\/a>),\u00a0SEC\u00a0filings, press releases, public conference calls and webcasts. Dar\u00e9 will use these channels to distribute material information about the company, and may also use social media to communicate important information about the company, its finances, product and product candidates, clinical trials and other matters. The information Dar\u00e9 posts on its investor relations website or through social media channels may be deemed to be material information. Dar\u00e9 encourages investors, the media, and others interested in the company to review the information Dar\u00e9 posts in the Investors section of its website and to follow these Twitter accounts: @SabrinaDareCEO and @DareBioscience. Any updates to the list of social media channels the company may use to communicate information will be posted in the Investors section of Dar\u00e9\u2019s website.<\/p>\n<p>\n        <strong>Contacts:<\/strong>\n      <\/p>\n<p>Investors on behalf of Dar\u00e9 Bioscience, Inc.:<br \/>Lee Roth <br \/>Burns McClellan<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=sslMd5goCTSIgAGeJFUzCndWHhoXh8giAuz0QjyYD66zIx_2Kp6WpSZdxVl1WgxntbA0w5ivf5oXwKB8GrqYzQ==\" rel=\"nofollow noopener\" target=\"_blank\">lroth@burnsmc.com<\/a><br \/>646.930.4406<\/p>\n<p>OR<\/p>\n<p>Media on behalf of Dar\u00e9\u00a0Bioscience, Inc.:<br \/>Jake Robison<br \/>Evoke Canale <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=FcW2jdKwZ4mEgvyjxCHoRAm6Z3gxDwtKdzQIK58wVI1sMrJJD1whQWGPJRCwI8GvzG6eucJp6iZOb1TKVSu-326OtY1uH1Ktj3Bd9cZnBX2DtajPYwLccJt9H7XbIe47\" rel=\"nofollow noopener\" target=\"_blank\">jake.robison@evokegroup.com<\/a><br \/>619.849.5383<\/p>\n<p>Source: Dar\u00e9 Bioscience, Inc.<\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMTMzNSM1NTczMTM4IzIwMDgzNjQ=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/YjBlOGQwY2QtODk5NC00YmIwLWE2ZjktMGE0N2FkZGI3NGNlLTEwMTk5Mzc=\/tiny\/Dar-Bioscience-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN DIEGO, May 04, 2023 (GLOBE NEWSWIRE) &#8212; Dar\u00e9 Bioscience, Inc. (NASDAQ: DARE), a leader in women\u2019s health innovation, today announced that it will host a conference call and live webcast at 4:30 p.m. Eastern Time on Thursday, May 11, 2023, to review its financial results for the quarter ended March 31, 2023 and to provide a Company update. To access the conference call via phone, dial (800) 715-9871 (U.S.) or (646) 307-1963 (international). The conference ID number for the call is 7046999. The live webcast can be accessed under \u201cPresentations, Events &amp; Webcasts&#8221; in the Investors section of the Company&#8217;s website at\u00a0http:\/\/ir.darebioscience.com. Please log in approximately 5-10 minutes prior to the call to register and to download and install &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-to-host-first-quarter-2023-financial-results-and-company-update-conference-call-and-webcast-on-may-11-2023\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Dar\u00e9 Bioscience to Host First Quarter 2023 Financial Results and Company Update Conference Call and Webcast on May 11, 2023&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-754909","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Dar\u00e9 Bioscience to Host First Quarter 2023 Financial Results and Company Update Conference Call and Webcast on May 11, 2023 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-to-host-first-quarter-2023-financial-results-and-company-update-conference-call-and-webcast-on-may-11-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Dar\u00e9 Bioscience to Host First Quarter 2023 Financial Results and Company Update Conference Call and Webcast on May 11, 2023 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO, May 04, 2023 (GLOBE NEWSWIRE) &#8212; Dar\u00e9 Bioscience, Inc. (NASDAQ: DARE), a leader in women\u2019s health innovation, today announced that it will host a conference call and live webcast at 4:30 p.m. Eastern Time on Thursday, May 11, 2023, to review its financial results for the quarter ended March 31, 2023 and to provide a Company update. To access the conference call via phone, dial (800) 715-9871 (U.S.) or (646) 307-1963 (international). The conference ID number for the call is 7046999. The live webcast can be accessed under \u201cPresentations, Events &amp; Webcasts&#8221; in the Investors section of the Company&#8217;s website at\u00a0http:\/\/ir.darebioscience.com. Please log in approximately 5-10 minutes prior to the call to register and to download and install &hellip; Continue reading &quot;Dar\u00e9 Bioscience to Host First Quarter 2023 Financial Results and Company Update Conference Call and Webcast on May 11, 2023&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-to-host-first-quarter-2023-financial-results-and-company-update-conference-call-and-webcast-on-may-11-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-04T13:42:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMTMzNSM1NTczMTM4IzIwMDgzNjQ=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dare-bioscience-to-host-first-quarter-2023-financial-results-and-company-update-conference-call-and-webcast-on-may-11-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dare-bioscience-to-host-first-quarter-2023-financial-results-and-company-update-conference-call-and-webcast-on-may-11-2023\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Dar\u00e9 Bioscience to Host First Quarter 2023 Financial Results and Company Update Conference Call and Webcast on May 11, 2023\",\"datePublished\":\"2023-05-04T13:42:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dare-bioscience-to-host-first-quarter-2023-financial-results-and-company-update-conference-call-and-webcast-on-may-11-2023\\\/\"},\"wordCount\":565,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dare-bioscience-to-host-first-quarter-2023-financial-results-and-company-update-conference-call-and-webcast-on-may-11-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzMTMzNSM1NTczMTM4IzIwMDgzNjQ=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dare-bioscience-to-host-first-quarter-2023-financial-results-and-company-update-conference-call-and-webcast-on-may-11-2023\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dare-bioscience-to-host-first-quarter-2023-financial-results-and-company-update-conference-call-and-webcast-on-may-11-2023\\\/\",\"name\":\"Dar\u00e9 Bioscience to Host First Quarter 2023 Financial Results and Company Update Conference Call and Webcast on May 11, 2023 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dare-bioscience-to-host-first-quarter-2023-financial-results-and-company-update-conference-call-and-webcast-on-may-11-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dare-bioscience-to-host-first-quarter-2023-financial-results-and-company-update-conference-call-and-webcast-on-may-11-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzMTMzNSM1NTczMTM4IzIwMDgzNjQ=\",\"datePublished\":\"2023-05-04T13:42:31+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dare-bioscience-to-host-first-quarter-2023-financial-results-and-company-update-conference-call-and-webcast-on-may-11-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dare-bioscience-to-host-first-quarter-2023-financial-results-and-company-update-conference-call-and-webcast-on-may-11-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dare-bioscience-to-host-first-quarter-2023-financial-results-and-company-update-conference-call-and-webcast-on-may-11-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzMTMzNSM1NTczMTM4IzIwMDgzNjQ=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzMTMzNSM1NTczMTM4IzIwMDgzNjQ=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dare-bioscience-to-host-first-quarter-2023-financial-results-and-company-update-conference-call-and-webcast-on-may-11-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Dar\u00e9 Bioscience to Host First Quarter 2023 Financial Results and Company Update Conference Call and Webcast on May 11, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Dar\u00e9 Bioscience to Host First Quarter 2023 Financial Results and Company Update Conference Call and Webcast on May 11, 2023 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-to-host-first-quarter-2023-financial-results-and-company-update-conference-call-and-webcast-on-may-11-2023\/","og_locale":"en_US","og_type":"article","og_title":"Dar\u00e9 Bioscience to Host First Quarter 2023 Financial Results and Company Update Conference Call and Webcast on May 11, 2023 - Market Newsdesk","og_description":"SAN DIEGO, May 04, 2023 (GLOBE NEWSWIRE) &#8212; Dar\u00e9 Bioscience, Inc. (NASDAQ: DARE), a leader in women\u2019s health innovation, today announced that it will host a conference call and live webcast at 4:30 p.m. Eastern Time on Thursday, May 11, 2023, to review its financial results for the quarter ended March 31, 2023 and to provide a Company update. To access the conference call via phone, dial (800) 715-9871 (U.S.) or (646) 307-1963 (international). The conference ID number for the call is 7046999. The live webcast can be accessed under \u201cPresentations, Events &amp; Webcasts&#8221; in the Investors section of the Company&#8217;s website at\u00a0http:\/\/ir.darebioscience.com. Please log in approximately 5-10 minutes prior to the call to register and to download and install &hellip; Continue reading \"Dar\u00e9 Bioscience to Host First Quarter 2023 Financial Results and Company Update Conference Call and Webcast on May 11, 2023\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-to-host-first-quarter-2023-financial-results-and-company-update-conference-call-and-webcast-on-may-11-2023\/","og_site_name":"Market Newsdesk","article_published_time":"2023-05-04T13:42:31+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMTMzNSM1NTczMTM4IzIwMDgzNjQ=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-to-host-first-quarter-2023-financial-results-and-company-update-conference-call-and-webcast-on-may-11-2023\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-to-host-first-quarter-2023-financial-results-and-company-update-conference-call-and-webcast-on-may-11-2023\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Dar\u00e9 Bioscience to Host First Quarter 2023 Financial Results and Company Update Conference Call and Webcast on May 11, 2023","datePublished":"2023-05-04T13:42:31+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-to-host-first-quarter-2023-financial-results-and-company-update-conference-call-and-webcast-on-may-11-2023\/"},"wordCount":565,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-to-host-first-quarter-2023-financial-results-and-company-update-conference-call-and-webcast-on-may-11-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMTMzNSM1NTczMTM4IzIwMDgzNjQ=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-to-host-first-quarter-2023-financial-results-and-company-update-conference-call-and-webcast-on-may-11-2023\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-to-host-first-quarter-2023-financial-results-and-company-update-conference-call-and-webcast-on-may-11-2023\/","name":"Dar\u00e9 Bioscience to Host First Quarter 2023 Financial Results and Company Update Conference Call and Webcast on May 11, 2023 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-to-host-first-quarter-2023-financial-results-and-company-update-conference-call-and-webcast-on-may-11-2023\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-to-host-first-quarter-2023-financial-results-and-company-update-conference-call-and-webcast-on-may-11-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMTMzNSM1NTczMTM4IzIwMDgzNjQ=","datePublished":"2023-05-04T13:42:31+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-to-host-first-quarter-2023-financial-results-and-company-update-conference-call-and-webcast-on-may-11-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-to-host-first-quarter-2023-financial-results-and-company-update-conference-call-and-webcast-on-may-11-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-to-host-first-quarter-2023-financial-results-and-company-update-conference-call-and-webcast-on-may-11-2023\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMTMzNSM1NTczMTM4IzIwMDgzNjQ=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMTMzNSM1NTczMTM4IzIwMDgzNjQ="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-to-host-first-quarter-2023-financial-results-and-company-update-conference-call-and-webcast-on-may-11-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Dar\u00e9 Bioscience to Host First Quarter 2023 Financial Results and Company Update Conference Call and Webcast on May 11, 2023"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/754909","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=754909"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/754909\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=754909"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=754909"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=754909"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}